Related Experiment Video
Updated: Apr 4, 2026
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Pharmaceutical services cost analysis using time-driven activity-based costing: A contribution to improve community
João Gregório1, Giuliano Russo1, Luís Velez Lapão1
1Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Rua da Junqueira, no 100, 1349-008 Lisboa, Portugal.
This study developed a time-driven activity-based costing (TDABC) model to determine pharmaceutical service costs. The model provides crucial insights for optimizing community pharmacy management and informing health policies.
Area of Science:
- Health Services Research
- Pharmaceutical Management
- Health Economics
Background:
- Healthcare systems face financial pressures, necessitating cost reduction and service improvement.
- Optimizing healthcare management, particularly pharmaceutical services, is critical but under-researched.
- Understanding resource utilization and associated costs is essential for pharmaceutical service efficiency.
Purpose of the Study:
- To develop a time-driven activity-based costing (TDABC) model for pharmaceutical services.
- To calculate the specific costs associated with various pharmaceutical services.
- To provide data for informed policy-making and improved pharmacy management.
Main Methods:
- An observational study was conducted in three community pharmacies over a weekday.
- Pharmacist time spent on each activity was meticulously recorded.
- Pharmacy cost data was extracted from accounting records.
Main Results:
- The cost per dispensing service ranged from €3.16 to €4.29.
- Counseling services (without medicine supply) cost between €1.24 and €1.46.
- Health screening services incurred costs from €2.86 to €4.55.
Conclusions:
- The TDABC model offers valuable insights into community pharmacy operations and costs.
- Cost analysis is vital for effective pharmaceutical service management.
- This research supports evidence-based policy development and pharmacy practice optimization.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
Related Concept Videos
01:20Chronopharmacokinetics: Time-Dependent Pharmacokinetics
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
01:05Noncompartmental Analysis: Mean Residence Time
After the administration of a drug through intravenous bolus injection, the drug molecules are distributed throughout the body and remain there for varying periods. The MRT represents the average time these drug molecules stay in the...
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
00:54Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
01:02Noncompartmental Analysis: Mean Transit, Absorption and Dissolution Time
One of the key parameters is the mean transit time (MTT), which refers to the total duration required for drug molecules to transit through the body. MTT is determined by calculating the ratio of the area under the moment curve to the area...